tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Arrowhead Pharmaceuticals (ARWR)
NASDAQ:ARWR
US Market
ARWR
Arrowhead Pharmaceuticals
RESEARCH TOOLSreports

Arrowhead Pharmaceuticals (ARWR) Stock News & Sentiment

Compare
1,658 Followers
Arrowhead Pharmaceuticals Issues Zero-Coupon 2032 Convertible Notes
Premium
Company Announcements
Arrowhead Pharmaceuticals Issues Zero-Coupon 2032 Convertible Notes
21d ago
8K
ARWR
Arrowhead’s ARO-DIMERPA Trial Advances in Mixed Hyperlipidemia: What Investors Should Watch
Premium
Company Announcements
Arrowhead’s ARO-DIMERPA Trial Advances in Mixed Hyperlipidemia: What Investors Should Watch
24d ago
ARWR
Arrowhead Pharmaceuticals Launches Major Equity and Notes Offerings
Premium
Company Announcements
Arrowhead Pharmaceuticals Launches Major Equity and Notes Offerings
24d ago
8K
ARWR
Arrowhead Reports Promising Interim Data for Obesity RNAi Trials
Premium
Company Announcements
Arrowhead Reports Promising Interim Data for Obesity RNAi Trials
27d ago
8K
ARWR
Analyst Recommends Buy Rating for Arrowhead Pharmaceuticals Due to Promising Obesity Treatment Potential
Premium
Ratings
Analyst Recommends Buy Rating for Arrowhead Pharmaceuticals Due to Promising Obesity Treatment Potential
2M ago
ARWR
Cautious Optimism for Arrowhead Pharmaceuticals Amid Competitor’s Positive Obesity Treatment Data
Premium
Ratings
Cautious Optimism for Arrowhead Pharmaceuticals Amid Competitor’s Positive Obesity Treatment Data
2M ago
ARWR
Arrowhead Pharmaceuticals at Risk: Potential Generic Competition Threatens REDEMPLO’s Market Exclusivity
Premium
Company Announcements
Arrowhead Pharmaceuticals at Risk: Potential Generic Competition Threatens REDEMPLO’s Market Exclusivity
2M ago
ARWR
More ARWR News >

ARWR News on the Web

Arrowhead doses first patient in ARO-DIMER-PA trial
TipRanks News
Bullish
Arrowhead price target raised to $101 from $61 at B. Riley
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Belite Bio, Inc. ADR (BLTE), Arrowhead Pharmaceuticals (ARWR) and Alector (ALEC)
TipRanks News
Bullish
Arrowhead price target raised to $100 from $85 at H.C. Wainwright
TipRanks News
Bullish
Sanofi Gains China NMPA Nod For Myqorzo And Redemplo In OHCM And FCS Treatments
rttnews
Neutral
Arrowhead price target raised to $110 from $100 at Piper Sandler
TipRanks News
Bullish
Piper Sandler Remains a Buy on Arrowhead Pharmaceuticals (ARWR)
TipRanks News
Neutral
Arrowhead Pharmaceuticals Issues Zero-Coupon 2032 Convertible Notes
TipRanks News
Neutral

News Score - Last 7 Days

Neutral
ARWR
Sector Average
Media Buzz
This Week1 articles
Weekly Average6.5 articles
News Sentiment
This Week100%
Sector Average73%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is ARWR’s Media Buzz Sentiment?
1 articles about ARWR were published this week. In an average week, 6.5 articles are published.
    What is ARWR’s weekly average amount of articles?
    In an average week, 6.5 articles about ARWR are published.
      What is ARWR’s News Sentiment?
      100% of articles about ARWR were positive this week, compared to its sector average of 73%.
        Healthcare Stocks that are Trending in the News
        HOCPFHOYA
        HVOOpen Orphan Plc
        CRDFCardiff Oncology
        QNCXQuince Therapeutics
        KRROKorro Bio
        Showing the stocks with the most bullish news sentiment over the past week